Applying the Evidence in CLL/SLL: Best Practices for Individualizing Therapy Selection

Gain a deeper understanding of therapies for chronic lymphocytic leukemia/small lymphocytic leukemia and how to incorporate evidence-based first-line therapies and sequencing strategies for relapsed/refractory disease through an expert-written ClinicalThought commentary, on-demand webcast, and accompanying downloadable resource and slides.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from Lilly and Merck Sharp & Dohme LLC.

Lilly

Merck Sharp & Dohme, LLC